DU Luping,LU Haiyan,HOU Liting,et al.Mechanism of immunopotentiator CVC1302 regulating somatic hypermutation[J].Journal of Huazhong Agricultural University,2025,44(01):211-216.
ISA206 was used to obtain the vaccine by emulsifying 4-hydroxy-3-nitrophenylacetyl conjugated chicken egg white protein (NP-OVA) with immunopotentiator CVC1302 to study the immune mechanism of CVC1302 regulating the occurrence of somatic hypermutation in germinal center B (
GC B) cells. Six-week-old BALB/c female mice were divided into 2 groups and immunized with NP-CVC1302-ISA206, NP-ISA206 in the hind leg muscles, with each mouse receiving 100 μL vaccine and 50 μg NP-OVA. Germinal center B cells were obtained with flow cytometry after14 days of immunization, and the variable region VH
186.2
gene sequence of immunoglobulin in GC B cells was amplified with nested-PCR. Western blot was used to detect the expression level of cytidine deaminase (AID) and Pax5 induced activation, and the differences in the expression level of AID and Pax5 between groups were compared with β-actin as an internal reference. The transcription level of
AID
and
Pax5
in GC B cells was analyzed with fluorescence quantitative PCR. The results showed that immunopotentiator CVC1302 significantly induced the mutation frequency of VH
186.2
in the immunoglobulin sequence of germinal center B cells, with a W33L mutation frequency of 62.2% in the NP-CVC1302 immunized group and only 20.25% in the NP immunized group. CVC1302 increased the expression level of AID protein and Pax5 protein in GC B cells. The relative expression level of AID protein in the NP-CVC1302 immunized group was 0.72, while that in the NP immunized group was only 0.16. The relative expression level of Pax5 protein in the NP-CVC1302 immunized group was 0.62, while that in the NP immunized group was only 0.26. CVC1302 enhanced the transcription level of
AID
gene and
Pax5
gene in the NP-CVC1302 immunized group, which was increased by 2.36 and 4.13 times compared to that in the NP immunized group. It is indicated that CVC1302 relies on Pax5 mediated AID expression to regulate the occurrence of somatic hypermutation in germinal center B cells.
关键词
Keywords
references
VICTORA G D, NUSSENZWEIG M C. Germinal centers[J]. Annual review of immunology, 2012,30:429-457.
YOUNG C, BRINK R. The unique biology of germinal center B cells[J]. Immunity, 2021,54(8):1652-1664.
MAYER C T, GAZUMYAN A, KARA E E, et al. The microanatomic segregation of selection by apoptosis in the germinal center[J/OL]. Science,2017,358(6360):eaao2602[2023-12-15]. https://doi.org/10.1126/science.aao2602.
WANG J H. The role of activation-induced deaminase in antibody diversification and genomic instability[J]. Immunologic research, 2013,55(1/2/3):287-297.
YU K F. AID function in somatic hypermutation and class switch recombination[J]. Acta biochimica et biophysica sinica, 2022,54(6):759-766.
CHEN Z G, WANG J H. Signaling control of antibody isotype switching[J]. Advances in immunology, 2019,141:105-164.
YEAP L S, MENG F L. Cis - and trans-factors affecting AID targeting and mutagenic outcomes in antibody diversification[J]. Advances in immunology, 2019,141:51-103.
LIN K I, ANGELIN-DUCLOS C, KUO T C, et al. Blimp-1-dependent repression of Pax - 5 is required for differentiation of B cells to immunoglobulin M-secreting plasma cells[J]. Molecular and cellular biology, 2002,22(13):4771-4780.
SCHRADER C E, LINEHAN E K, MOCHEGOVA S N, et al. Inducible DNA breaks in Ig S regions are dependent on AID and UNG[J]. The journal of experimental medicine,2005,202(4):561-568.
CHEN J, YU X M, ZHENG Q S, et al. The immunopotentiator CVC1302 enhances immune efficacy and protective ability of foot-and-mouth disease virus vaccine in pigs[J]. Vaccine, 2018,36(52):7929-7935.
DU L P, CHEN J, HOU L T, et al. Long-term humoral immunity induced by CVC1302-adjuvanted serotype O foot-and-mouth disease inactivated vaccine correlates with promoted T follicular helper cells and thus germinal center responses in mice[J]. Vaccine, 2017,35(51):7088-7094.
DU L P, HOU L T, YU X M, et al. Pattern-recognition receptor agonist-containing immunopotentiator CVC1302 boosts high-affinity long-lasting humoral immunity[J/OL]. Frontiers in immunology, 2021,12:697292[2023-12-15]. https://doi.org/10.3389/fimmu.2021.697292.
RIVERA C E, ZHOU Y L, CHUPP D P, et al. Intrinsic B cell TLR-BCR linked coengagement induces class-switched, hypermutated, neutralizing antibody responses in absence of T cells[J/OL]. Science advances,2023,9(17):eade8928[2023-12-15]. http://doi.org/10.1126/sciadv.ade8928.
GITLIN A D, MAYER C T, OLIVEIRA T Y, et al. T cell help controls the speed of the cell cycle in germinal center B cells[J]. Science,2015,349(6248):643-646.
NAGAOKA H, TRAN T H, KOBAYASHI M, et al. Preventing AID, a physiological mutator, from deleterious activation: regulation of the genomic instability that is associated with antibody diversity[J]. International immunology, 2010,22(4):227-235.
CHEN D Y, WANG Y, VIJAY G K M, et al. Coupled analysis of transcriptome and BCR mutations reveals role of OXPHOS in affinity maturation[J]. Nature immunology,2021,22(7):904-913.